Fulgent Genetics Inc expected to post a loss of 33 cents a share - Earnings Preview

Fulgent Genetics

02/08/2023 13:56

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 4. 
    * The El Monte California-based  company is expected to
report  a
50.1% decrease in revenue to $62.483 million from $125.34
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on May
5 2023, for the period ended June 30, was for revenue of $62.000
million.
    * ​Refinitiv's mean analyst estimate for Fulgent Genetics
Inc is
for a loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $45​, above​ its last closing price of $38.83. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.43       -0.43      -0.22     Beat    48.4
 Dec. 31 2023  -0.56       -0.56      -0.48     Beat    14.3
 Sep. 30 2022  0.05        0.05       0.32      Beat    498.1​
 Jun. 30 2022  0.73        0.73       0.78      Beat    6.8
 ​​Mar.        3.84        3.86       5.08      Beat    31.6
 31 2022                                                
 Dec. 31 2021  2.61        2.61       3.34      Beat    28.1​
 Sep. 30 2021  3.25        3.25       3.95      Beat    21.7
 Jun. 30 2021  2.78        2.76       2.47      Missed  -10.4
 This summary was machine generated August 2 at 12:56 GMT.  All
figures in US dollars  unless otherwise stated